| OCUL Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the OCUL shares outstanding history going back to 7/25/2014:
Also see: OCUL Market Cap History OCUL YTD Return |
OCUL Shares Outstanding History — Ocular Therapeutix Share Count Over Time
As of 5/1/2026 Ocular Therapeutix has 218.96 million OCUL shares outstanding. Investors often track the OCUL shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows OCUL share count trends over time, with 49 historical shares outstanding datapoints presented, dating back to 7/25/2014.
| OCUL Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OCUL Historical Shares Outstanding: +22.24% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| OCUL Stock Price Chart |
| About Ocular Therapeutix Inc |
| Ocular Therapeutix, Inc. is a biopharmaceutical company engaged in the development and commercialization therapies for eye conditions, including wet age-related macular degeneration (wet AMD), diabetic retinopathy and other ocular diseases. Co.'s commercial product, DEXTENZA, treats ocular inflammation and pain following eye surgery and ocular itching due to allergic conjunctivitis. Co. is also developing OTX-DED for short-term dry eye disease treatment and OTX-CSI for chronic dry eye disease management. It is conducting a Phase III trial for AXPAXLI to treat wet AMD and are also advancing PAXTRAVA in Phase III clinical development for primary open-angle glaucoma or ocular hypertension. We show 49 historical shares outstanding datapoints in our coverage of OCUL's shares outstanding history. Understanding the changing numbers of OCUL shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like OCUL versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching OCUL by allowing them to research OCUL shares outstanding history as well as any other stock in our coverage universe. |
| OCUL Current Stock Quote |
Quotes delayed 20 minutes  Free OCUL Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| OCUL Share Performance |
| Shares Outstanding Peers |
| Ocular Therapeutix (OCUL) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
OCUP Shares Outstanding History OCX Shares Outstanding History ODT Shares Outstanding History ODYS Shares Outstanding History OFIX Shares Outstanding History OGN Shares Outstanding History OHRP Shares Outstanding History OKUR Shares Outstanding History OLMA Shares Outstanding History OM Shares Outstanding History More Healthcare companies » |
OCUL Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
